Immatics N.V. - (IMTX) closed at $6.36 on November 6, 2026, up 2.9% from the previous close, on volume of 1,006,568 shares (30-day average 1,058,001).
Data as of November 6, 2026.
6-Nov-2026
Globe Newswire (Sat, 24-Oct 2:30 AM ET)
Immatics Announces $150 Million Underwritten Offering
Globe Newswire (Tue, 25-Aug 7:00 AM ET)
Immatics Announces Second Quarter 2026 Financial Results and Business Update
Globe Newswire (Tue, 18-Aug 7:00 AM ET)
Immatics Launches $125 Million Underwritten Offering—What Could This Mean for Its Clinical Pipeline?
Market Chameleon (Fri, 5-Dec 4:01 AM ET)
Market Chameleon (Mon, 17-Nov 2:09 AM ET)
Market Chameleon (Wed, 12-Nov 2:08 AM ET)
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Immatics N.V. - trades on the NASDAQ stock market under the symbol IMTX.
As of November 6, 2026, IMTX stock price climbed to $6.36 with 1,006,568 million shares trading.
IMTX has a beta of 1.62, meaning it tends to be more sensitive to market movements. IMTX has a correlation of 0.20 to the broad based SPY ETF.
IMTX has a market cap of $968.15 million. This is considered a Small Cap stock.
Last quarter Immatics N.V. - reported $11 million in Revenue and -$.53 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.10.
In the last 3 years, IMTX traded as high as $13.77 and as low as $3.30.
The top ETF exchange traded funds that IMTX belongs to (by Net Assets): SPDW, SBIO, KOMP, CANC, ONEQ.
IMTX has underperformed the market in the last year with a price return of -28.9% while the SPY ETF gained +9.6%. IMTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.9% and -15.6%, respectively, while the SPY returned -4.2% and -3.8%, respectively.
IMTX support price is $5.91 and resistance is $6.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMTX shares will trade within this expected range on the day.
